DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
Clinical trial NCT06203132 · RECRUITING
Trial details
- NCT number
- NCT06203132
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-27
- Primary completion
- 2028-01-01
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.